Exablate Blood-Brain Barrier Disruption device
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Exablate Blood-Brain Barrier Disruption device, covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy [EARLY_Phase 1]